Suppr超能文献

[短期强化化疗(STIC)联合静脉高营养治疗晚期胃癌]

[Short-term intensive chemotherapy (STIC) combined with intravenous hyperalimentation in advanced stomach cancer].

作者信息

Maeta M, Koga S, Shimizu N, Osaki Y, Kanayama H, Hamazoe R, Yamane T, Karino T, Oda M

出版信息

Gan To Kagaku Ryoho. 1983 Nov;10(11):2370-6.

PMID:6416183
Abstract

A short-term intensive chemotherapy (STIC) consisting of large dose of mitomycin C (MMC), tegafur (FT-207), streptococcus preparation picibanil (OK-432) and Krestin (PSK), combined with IVH was performed in 72 patients with advanced gastric cancer. Thirty-three patients were unresectable and 39 patients were recurrent. In this modality, an intensive chemotherapy was able to carry out, maintaining, or increasing in host immunologic parameters and body weight in spite of their disturbed condition in oral food take. Partial response was obtained in 10 of 51 evaluable cases (19.6%) and the survival period on STIC was superior to that on controls. However, no significant difference was observed between the two groups. Four patients had become to be able to take full oral food again by STIC and resulted in the removal of IVH. Hyperglycemia and septicaemia induced by IVH were observed in 9 of 72 patients (12.5%), one died of septicaemia. Full attention should be paid in the management of IVH for patients with advanced cancer.

摘要

对72例晚期胃癌患者实施了短期强化化疗(STIC),该化疗方案由大剂量丝裂霉素C(MMC)、替加氟(FT - 207)、链球菌制剂匹多莫德(OK - 432)和云芝多糖K(PSK)组成,并联合静脉高营养(IVH)。其中33例患者无法切除,39例患者复发。在这种治疗方式下,尽管患者口服进食情况不佳,但强化化疗仍能够实施,并且宿主免疫参数和体重得以维持或增加。51例可评估病例中有10例(19.6%)获得部分缓解,接受STIC治疗的患者生存期优于对照组。然而,两组之间未观察到显著差异。4例患者通过STIC治疗后再次能够正常口服进食,从而停止了IVH。72例患者中有9例(12.5%)出现了由IVH引起的高血糖和败血症,其中1例死于败血症。对于晚期癌症患者,在IVH管理中应给予充分关注。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验